注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Lisata Therapeutics Inc(原名:Caladrius Biosciences, Inc.),是一家臨床階段的生物製藥公司。該公司從事治療晚期實體瘤和其他主要疾病的療法的發現、開發和商業化。該公司主要專注於在一系列腫瘤適應症中推進其CendR平台技術產品候選者。該公司的主要研究產品候選者LSTA1旨在通過激活允許抗癌藥物穿透實體瘤的攝取途徑來改變腫瘤微環境。LSTA1以腫瘤特異性方式激活主動轉運系統,導致系統性共同給藥的抗癌藥物在腫瘤中滲透和積累,而正常組織不受影響。此外,該公司還擁有基於自體CD34+細胞治療技術平台的臨床開發項目。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Gregory Bailey Brown | 67 | 2016 | Independent Chairman of the Board |
Robert S. Negrin | - | - | Immune Modulation Program Advisor |
Timothy D. Henry | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Joseph C. Wu | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
David A. Horwitz | - | - | Immune Modulation Program Advisor |
Mark Peakman | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Thomas J. Povsic | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Andreas Zeiher | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Todd Brusko | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Robert Korngold | - | - | Immune Modulation Program Advisor |
Noel L. Warner | - | - | Immune Modulation Program Advisor |
David Pearce | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Arshed A. Quyyumi | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Cathleen Noel Bairey Merz | 66 | 2019 | Member of Cardiovascular Disease Scientific Advisory Board |
David Peritt | 57 | - | Immune Modulation Program Advisor |
Gerald T. Nepom | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Richard A. Schatz | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Kevan Herold | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Cynthia L. Flowers | 62 | 2018 | Independent Director |
Christopher J. White | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Laurence A. Turka | 64 | - | Member of Type 1 Diabetes Scientific Advisory Board |
Michael Gibson | - | 2019 | Member of Cardiovascular Disease Scientific Advisory Board |
William Fearon | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Steven M. Klosk | 66 | 2014 | Independent Director |
Mohammad Azab | 67 | 2022 | Independent Director |
Heidi Henson | 57 | 2022 | Independent Director |
David J. Mazzo | 66 | 2015 | President, CEO & Director |
Erkki Ruoslahti | 82 | 2022 | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核